Epithalon and Selank represent two distinct classes of synthetic peptides widely evaluated across cellular, neurological, and physiological research models. This comparative analysis examines their divergent molecular structures, underlying primary mechanisms, stability profiles, and ideal laboratory study designs.
Epithalon and Selank represent two distinct classes of synthetic peptides widely evaluated across cellular, neurological, and physiological research models. This comparative analysis examines their divergent molecular structures, underlying primary mechanisms, stability profiles, and ideal laboratory study designs.
Epithalon (Ala-Glu-Asp-Gly) is a synthetic pineal bioregulator peptide primarily studied for telomerase activation, telomere elongation, and circadian cycle regulation in longevity models. In contrast, Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic heptapeptide tuftsin analog evaluated for GABAergic neuromodulation, neuroprotective pathways, and immune-system interaction in central nervous system research.
While both agents are low-molecular-weight short-chain peptides derived from endogenous biological signaling molecules, their molecular targets and observed cellular pathways do not overlap. Epithalon acts primarily at the chromatin and gene transcription level within endocrine and somatic tissues, whereas Selank acts predominantly as a neuromodulator across neurotransmitter and cytokine signaling networks. Researchers selecting between these compounds must align their experimental designs with the appropriate cellular target, assay type, and mechanistic endpoints.
To assist laboratory principal investigators in selecting the correct standard for comparative protocols, the primary chemical, physical, and mechanistic parameters of both compounds are contrasted below:
- Molecular Structure: Epithalon is a tetrapeptide (Ala-Glu-Asp-Gly; MW ~390.35 g/mol); Selank is a heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro; MW ~751.9 g/mol). - Primary Mechanistic Class: Epithalon is classified as a synthetic pineal peptide bioregulator; Selank is classified as a synthetic tuftsin-derived neuromodulatory peptide. - Targeted Biological Systems: Epithalon targets nuclear DNA/epigenetic machinery, pineal gland function, and telomerase activity; Selank targets the central nervous system, GABAergic receptors, and BDNF expression. - Estimated Preclinical Half-Life: Epithalon exhibits a brief plasma half-life (~10–20 minutes in rodent models); Selank exhibits rapid enzymatic degradation in plasma (~2–5 minutes) but sustained central tissue effects via peptide fragment dynamics. - Standard Reconstitution Solvent: Both compounds dissolve readily in sterile bacteriostatic water or standard phosphate-buffered saline (PBS, pH 7.4). - Primary Assay Types: Epithalon is used in qPCR telomere length assays, Western blots for hTERT, and melatonin secretion assays; Selank is used in radioligand binding, electrophysiology, neuroinflammation models, and elevated plus maze behavior assays.
Researchers looking to evaluate these compounds can access high-purity Epithalon synthetic peptide and Selank research powder from our verified laboratory inventory.
Epithalon (also known as Epitalon or Epithalone) was designed to mimic the active sequence of epithalamin, a natural peptide extract isolated from the pineal gland. Composed of four amino acid residues (L-alanyl-L-glutamyl-L-aspartyl-glycine), Epithalon possesses an exceptionally low molecular mass that facilitates rapid intracellular diffusion and nuclear envelope penetration in cell culture models. Its carboxyl and hydroxyl functional groups interact with specific histone proteins and promoter regions of nuclear DNA.
Selank is a heptapeptide derivative of the naturally occurring immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg), elongated at the C-terminus with a Pro-Gly-Pro tripeptide motif. The addition of the C-terminal Pro-Gly-Pro sequence enhances resistance to vascular carboxypeptidases and aminopeptidases compared to endogenous tuftsin, granting the molecule altered stability kinetics in vitro. The basic arginine and lysine residues grant Selank a high affinity for membrane-bound neuronal receptors and cell surface transport sites.
Preclinical investigations into Epithalon focus primarily on its capacity to modulate gene expression and maintain genomic stability. In vitro studies utilizing human somatic cell lines demonstrate that Epithalon induces the expression of the catalytic subunit of telomerase (hTERT). By promoting telomerase enzyme activity, the peptide facilitates the de novo addition of TTAGGG hexanucleotide repeats to chromosome ends, delaying senescence in cultured fibroblast models.
Beyond telomere dynamics, rodent studies suggest Epithalon exerts a direct regulatory effect on the pineal gland, restoring nocturnal melatonin synthesis and regulating chromatin accessibility. Epithalon has been shown to interact directly with the promoter regions of genes encoding pineal proteins and antioxidant enzymes, such as superoxide dismutase (SOD) and glutathione peroxidase. In long-term rodent longevity trials, chronic administration of Epithalon was observed to normalize biological rhythms, lower spontaneous tumor incidence, and suppress oxidative lipid peroxidation.
Selank operates through a multi-target neuromodulatory mechanism within the central nervous system. In vitro electrophysiological studies reveal that Selank modulates gamma-aminobutyric acid (GABA) signaling by acting as an allosteric modulator at GABA-A receptor complexes. Unlike classical benzodiazepines, Selank does not bind directly to the benzodiazepine recognition site; rather, it alters receptor affinity for GABA, enhancing inhibitory neurotransmission without causing receptor downregulation or ion channel desensitization.
Additionally, animal studies demonstrate that Selank rapidly upregulates the expression of Brain-Derived Neurotrophic Factor (BDNF) and its primary receptor, TrkB, within the hippocampus. This neurotrophic stimulation is accompanied by changes in monoamine metabolism, specifically modulating serotonin (5-HT) and dopamine turnover rates. Concurrently, due to its structural heritage from tuftsin, Selank alters interleukin-6 (IL-6) expression and modulates peripheral immune cell activity, making it a critical reference compound in neuroimmunology research.
Understanding the breakdown pathways and structural stability of Epithalon vs Selank is vital for designing reproducible bench protocols. Epithalon, being a short tetrapeptide, is vulnerable to rapid cleavage by systemic peptidases if introduced to serum-rich media without enzyme inhibitors. However, due to its small size, its degraded amino acid constituent fragments are non-toxic and easily reutilized in cellular protein synthesis. In serum-free cell culture media, Epithalon remains intact long enough to achieve cell entry via passive transport or fluid-phase endocytosis.
Selank features improved peptide bond stability over its parent molecule tuftsin due to the C-terminal Pro-Gly-Pro tail. Nevertheless, in whole blood or tissue homogenate assays, Selank undergoes sequential enzymatic cleavage into active sub-fragments (such as Thr-Lys-Pro-Arg and Gly-Pro). Preclinical studies indicate that these metabolic degradation products retain bioactivity at neuronal receptor sites, effectively extending the functional biological response far beyond the parent compound's brief plasma half-life. Laboratory investigators often utilize protease inhibitor cocktails when assessing exact parent-peptide concentrations in pharmacokinetic assays.
When designing comparative research panels, Epithalon and Selank are frequently grouped with other synthetic bioregulators and central nervous system peptides. Epithalon shares mechanistic classification with short-chain bioregulators such as Pinealon bioregulator peptide, which selectively targets neuronal gene expression, and Thymalin research peptide, an immunomodulatory bioregulator derived from thymic tissue models.
Conversely, Selank is most directly compared to Semax cognitive research peptide, an ACTH(4-10) analog that similarly targets BDNF upregulation and neuroprotection, albeit with a stronger emphasis on melanocortin signaling rather than GABAergic modulation. Researchers evaluating our complete catalog of research peptides often construct multi-arm study designs incorporating both bioregulatory peptides and neurotropic agents to contrast nuclear-level transcriptional effects against cell-surface receptor signaling cascades.
Selecting whether to utilize Epithalon or Selank depends entirely on the pre-specified primary endpoints of the research protocol:
- Choose Epithalon for protocols measuring cellular senescence, telomere length (via qPCR or FISH assays), hTERT mRNA expression, pineal gland function, circadian rhythm restoration, or oxidative stress markers in aging cell models. - Choose Selank for protocols investigating GABA-A receptor kinetics, neurotrophic factor expression (BDNF/NGF), behavioral paradigms of stress or anxiety in rodent models (e.g., elevated plus maze, open field test), or neuroinflammatory cytokine cascades.
For complex translational models examining systemic biological aging, researchers occasionally employ both peptides in distinct, non-overlapping experimental arms to evaluate independent signaling axes. For comprehensive technical protocols and compound background papers, researchers can explore our dedicated PX1 scientific research library.
Both Epithalon and Selank are supplied as sterile, lyophilized powders to maximize shelf stability during transport and storage. Upon receipt, unopened vials should be stored at -20°C in a dry environment protected from light. Prior to reconstitution, vials should be allowed to equilibrate to room temperature to prevent condensation within the container.
Reconstitution should be performed using sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile normal saline, depending on the requirements of the targeted assay. Gentle swirl agitation should be applied; high-shear vortexing must be avoided as it can induce peptide denaturation or aggregation. To calculate precise concentration volumes for micro-dosing cell culture wells or microdialysis systems, scientists should utilize our free online peptide reconstitution calculator. Reconstituted solutions should be aliquoted into single-use polypropylene microtubes and stored at -80°C to prevent freeze-thaw degradation cycles.
To ensure high experimental reproducibility, PX1 Research subjects every batch of synthetic peptides to rigorous analytical testing in ISO 17025 accredited laboratories. Epithalon and Selank are synthesized using standard solid-phase peptide synthesis (SPPS) under strict GMP-compliant manufacturing frameworks.
Purity is verified using high-performance liquid chromatography (HPLC), ensuring a minimum purity profile of ≥99.0%. Molecular mass identity is confirmed via electrospray ionization mass spectrometry (ESI-MS) to eliminate the risk of sequence truncation or amino acid substitution errors. Furthermore, every lot undergoes chromogenic LAL testing to confirm endotoxin levels remain strictly below <0.05 EU/mg, preventing confounding inflammatory responses in sensitive cell cultures or in vivo models. Investigators can download lot-specific documentation directly via our dedicated certificate of analysis database. For large-scale institutional projects, custom packaging options are available through our bulk research accounts.
What is the core structural difference between Epithalon and Selank?
Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from pineal peptide structures, whereas Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) derived from the immunomodulatory peptide tuftsin.
Can Epithalon and Selank be used interchangeably in research assays?
No. They target entirely distinct physiological mechanisms. Epithalon is studied for telomerase activity, DNA repair, and pineal/circadian regulation, while Selank is studied for GABAergic modulation, BDNF expression, and central nervous system dynamics.
What solvents are recommended for reconstituting Epithalon and Selank?
Both lyophilized peptides dissolve readily in sterile bacteriostatic water, sterile 0.9% sodium chloride, or standard phosphate-buffered saline (PBS, pH 7.4) for laboratory assays.
How should reconstituted peptide solutions be stored for long-term studies?
Reconstituted solutions should be divided into single-use aliquots to avoid repeated freeze-thaw cycles and stored at -80°C. Short-term storage (under 7 days) can be maintained at 4°C.
What analytical methods verify the purity of PX1 Research peptides?
Every lot is analyzed via High-Performance Liquid Chromatography (HPLC) to verify chemical purity (≥99.0%) and Mass Spectrometry (MS) to confirm exact molecular weight and sequence identity.
Are these compounds tested for bacterial endotoxins?
Yes. Every batch undergoes chromogenic Limulus Amebocyte Lysate (LAL) assay testing to guarantee endotoxin levels are strictly below <0.05 EU/mg.
What preclinical models are typically used to evaluate Selank?
Selank is commonly evaluated in rodent electrophysiology models, hippocampal cell cultures for BDNF expression, radioligand binding assays for GABA receptors, and behavioral maze paradigms.
What preclinical models are used for Epithalon longevity research?
Epithalon is primarily studied in cultured human somatic cells (evaluating hTERT transcript levels and telomere length via qPCR) and aging rodent models measuring oxidative stress and tumor suppression.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.